Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

Infection with Chlamydia trachomatis increases the risk of high grade anal intraepithelial neoplasia in people living with HIV.

Masiá M, Fernández-González M, García JA, Padilla S, García-Payá E, Gutiérrez A, Ortiz de la Tabla V, García-Abellán J, Agulló V, Gutiérrez F.

Clin Infect Dis. 2019 Jul 4. pii: ciz606. doi: 10.1093/cid/ciz606. [Epub ahead of print]

PMID:
31271192
2.

Evolving understanding of cardiovascular, cerebrovascular and peripheral arterial disease in people living with HIV and role of novel biomarkers. A study of the Spanish CoRIS cohort, 2004-2015.

Masiá M, Padilla S, García JA, García-Abellán J, Fernández M, Bernardino I, Montero M, Peraire J, Pernas B, Gutiérrez F.

PLoS One. 2019 Apr 26;14(4):e0215507. doi: 10.1371/journal.pone.0215507. eCollection 2019.

3.

Social deprivation indexes and anti-influenza vaccination coverage in the elderly in Sardinia, Italy, with a focus on the Sassari municipality.

Arghittu A, Dettori M, Masia MD, Azara A, Dempsey E, Castiglia P.

J Prev Med Hyg. 2019 Feb 28;59(4 Suppl 2):E45-E50. doi: 10.15167/2421-4248/jpmh2018.59.4s2.1077. eCollection 2018 Dec.

4.

Population Distrust of Drinking Water Safety. Community Outrage Analysis, Prediction and Management.

Dettori M, Azara A, Loria E, Piana A, Masia MD, Palmieri A, Cossu A, Castiglia P.

Int J Environ Res Public Health. 2019 Mar 20;16(6). pii: E1004. doi: 10.3390/ijerph16061004.

5.

Contribution of Human Herpesvirus 8 and Herpes Simplex Type 2 to Progression of Carotid Intima-Media Thickness in People Living With HIV.

Lidón F, Padilla S, García JA, Fernández M, García J, Ortiz de la Tabla V, Gutiérrez F, Masiá M.

Open Forum Infect Dis. 2019 Jan 29;6(2):ofz041. doi: 10.1093/ofid/ofz041. eCollection 2019 Feb.

6.

Risk of cancer in HIV-infected patients in Spain, 2004-2015. The CoRIS cohort study.

García-Abellán J, Del Río L, García JA, Padilla S, Vivancos MJ, Del Romero J, Asensi V, Hernando A, García-Fraile L, Masiá M, Gutiérrez F; la Cohorte de la Red Nacional de Sida (CoRIS).

Enferm Infecc Microbiol Clin. 2019 Jan 22. pii: S0213-005X(18)30382-3. doi: 10.1016/j.eimc.2018.11.011. [Epub ahead of print] English, Spanish.

PMID:
30679001
7.

Derogation from drinking water quality standards in Italy according to the European Directive 98/83/EC and the Legislative Decree 31/2001 - a look at the recent past.

Azara A, Castiglia P, Piana A, Masia MD, Palmieri A, Arru B, Maida G, Dettori M.

Ann Ig. 2018 Nov-Dec;30(6):517-526. doi: 10.7416/ai.2018.2263.

8.

Congenital HIV infection after failure of serological screening. Importance of implementing a second screening for HIV infection during the third trimester of pregnancy.

García-Abellán J, Padilla S, Serrano MI, Masiá M.

Enferm Infecc Microbiol Clin. 2018 Oct 30. pii: S0213-005X(18)30270-2. doi: 10.1016/j.eimc.2018.09.010. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
30389266
9.

A "lipo-tourist" with chronic cutaneous lesions after surgery in Ecuador: A diagnostic challenge.

Llenas-García J, Vicente J, Ruiz-García MM, Valencia-Ramírez I, Masiá M.

Travel Med Infect Dis. 2018 Sep - Oct;25:77-78. doi: 10.1016/j.tmaid.2018.07.013. Epub 2018 Aug 1. No abstract available.

PMID:
30075310
10.

Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study.

Gatell JM, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Martinez E, Stellbrink HJ, Guaraldi G, Masia M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Stephan C, Rockstroh J, Giacomelli A, Vera J, Bernardino JI, Winston A, Saumoy M, Gras J, Katlama C, Pozniak AL; European Network for AIDS Treatment 022 (NEAT022) Study Group .

Clin Infect Dis. 2019 Feb 1;68(4):597-606. doi: 10.1093/cid/ciy505.

PMID:
29912307
11.

Decreasing rates of acute myocardial infarction in people living with HIV: a nationwide cohort study in Spain, 2004-2015.

Masiá M, Padilla S, García JA, Bernardino JI, Campins AA, Asensi V, Gutiérrez F; Cohort of HIV Adults of the AIDS Research Network (CoRIS) study.

HIV Med. 2018 Apr 23. doi: 10.1111/hiv.12616. [Epub ahead of print]

PMID:
29683252
12.

High-grade anal intraepithelial neoplasia is associated with HIV-1 RNA rectal shedding in virologically suppressed MSM.

García-Payá E, Fernández M, Padilla S, García JA, Robledano C, de la Tabla VO, Gutiérrez F, Masiá M.

AIDS. 2018 May 15;32(8):1017-1024. doi: 10.1097/QAD.0000000000001794.

PMID:
29547439
13.

Evaluation of the Virclia® automated chemiluminescent immunoassay system for diagnosing pneumonia caused by Mycoplasma pneumoniae.

Ortiz de la Tabla V, Berruezo M, García Payá E, Fernández M, García JA, Masiá M, Gutiérrez F.

J Clin Lab Anal. 2018 Mar 6. doi: 10.1002/jcla.22431. [Epub ahead of print]

PMID:
29508444
14.

Role of HIV in the desire of procreation and motherhood in women living with HIV in Spain: a qualitative approach.

Alvarez-Del Arco D, Rodríguez S, Pérez-Elías MJ, Blanco JR, Cuellar S, Del Romero J, Santos I, Boix V, Masiá M, Pascual L, Hernando V; CoRIS.

BMC Womens Health. 2018 Jan 24;18(1):24. doi: 10.1186/s12905-017-0483-y.

15.

Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients.

Mínguez C, García-Deltoro M, Flores J, Galindo MJ, Montero M, Reus S, Carmena J, Masiá M, Amador C, Ortega E; on the behalf of the COINFECOVA-2 study group.

AIDS. 2018 Jan 28;32(3):337-346. doi: 10.1097/QAD.0000000000001699.

PMID:
29309345
16.

Sofosbuvir plus daclatasvir as an alternative for patients on haemodialysis with genotype 2 hepatitis C virus infection.

Llenas-García J, Padilla S, Masiá M, Gutiérrez F.

Enferm Infecc Microbiol Clin. 2018 Aug - Sep;36(7):457. doi: 10.1016/j.eimc.2017.10.012. Epub 2017 Dec 6. English, Spanish. No abstract available.

PMID:
29217095
17.

Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM.

Serrano-Villar S, Hernández-Novoa B, de Benito A, Del Romero J, Ocampo A, Blanco JR, Masiá M, Sendagorta E, Sanz G, Moreno S, Pérez-Molina JA.

PLoS One. 2017 Nov 30;12(11):e0188851. doi: 10.1371/journal.pone.0188851. eCollection 2017.

18.

Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk.

Gatell JM, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Martinez E, Stellbrink HJ, Guaraldi G, Masia M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Pozniak AL; NEAT022 Study Group*.

AIDS. 2017 Nov 28;31(18):2503-2514. doi: 10.1097/QAD.0000000000001675.

19.

Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach.

Masiá M, Padilla S, Moreno S, Barber X, Iribarren JA, Del Romero J, Gómez-Sirvent JL, Rivero M, Vidal F, Campins AA, Gutiérrez F; Cohorte de la Red de Investigación en Sida (CoRIS).

PLoS One. 2017 Sep 8;12(9):e0184329. doi: 10.1371/journal.pone.0184329. eCollection 2017.

20.

Developments in early diagnosis and therapy of HIV infection in newborns.

Canals F, Masiá M, Gutiérrez F.

Expert Opin Pharmacother. 2018 Jan;19(1):13-25. doi: 10.1080/14656566.2017.1363180. Epub 2017 Aug 11. Review.

PMID:
28764578
21.

Executive summary of the consensus document on osteoporosis in HIV-infected individuals.

Negredo E, Domingo P, Gutiérrez F, Galindo MJ, Knobel H, Lozano F, Martínez E, Masiá M, Polo R, Estrada V.

Enferm Infecc Microbiol Clin. 2018 May;36(5):312-314. doi: 10.1016/j.eimc.2017.03.010. Epub 2017 May 31. English, Spanish.

PMID:
28579014
22.

Procalcitonin for selecting the antibiotic regimen in outpatients with low-risk community-acquired pneumonia using a rapid point-of-care testing: A single-arm clinical trial.

Masiá M, Padilla S, Ortiz de la Tabla V, González M, Bas C, Gutiérrez F.

PLoS One. 2017 Apr 20;12(4):e0175634. doi: 10.1371/journal.pone.0175634. eCollection 2017.

23.

Severe skull base osteomyelitis caused by Pseudomonas aeruginosa with successful outcome after prolonged outpatient therapy with continuous infusion of ceftazidime and oral ciprofloxacin: a case report.

Conde-Díaz C, Llenas-García J, Parra Grande M, Terol Esclapez G, Masiá M, Gutiérrez F.

J Med Case Rep. 2017 Feb 21;11(1):48. doi: 10.1186/s13256-017-1221-7.

24.

Statins in HIV-Infected Patients: Potential Beneficial Effects and Clinical Use.

Bernal E, Marín I, Masiá M, Gutiérrez F.

AIDS Rev. 2017 Apr - Jun;19(2):59-71. Review.

PMID:
28182617
25.

Contribution of Oxidative Stress to Non-AIDS Events in HIV-Infected Patients.

Masiá M, Padilla S, Fernández M, Barber X, Moreno S, Iribarren JA, Portilla J, Peña A, Vidal F, Gutiérrez F; CoRIS.

J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):e36-e44. doi: 10.1097/QAI.0000000000001287.

PMID:
28107228
26.

Glioblastoma with oligodendroglioma component in a ewe.

Pintus D, Marruchella G, Masia M, Maestrale C, Cancedda MG, Contu C, Macciocu S, Ligios C.

J Vet Diagn Invest. 2016 Jul;28(4):449-54. doi: 10.1177/1040638716644646. Epub 2016 May 6.

PMID:
27154317
27.

Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients.

Masiá M, Padilla S, Fernández M, Rodríguez C, Moreno A, Oteo JA, Antela A, Moreno S, Del Amo J, Gutiérrez F; CoRIS, Biobanco.

PLoS One. 2016 Apr 25;11(4):e0153456. doi: 10.1371/journal.pone.0153456. eCollection 2016.

28.

The CD4/CD8 Ratio is Inversely Associated with Carotid Intima-Media Thickness Progression in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Treatment.

Bernal Morell E, Serrano Cabeza J, Muñoz Á, Marín I, Masiá M, Gutiérrez F, Cano A.

AIDS Res Hum Retroviruses. 2016 Jul;32(7):648-53. doi: 10.1089/AID.2015.0385. Epub 2016 Apr 20.

PMID:
27005326
29.

Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio: A Cohort Study.

Masiá M, Padilla S, Barber X, Sanchis M, Terol G, Lidón F, Gutiérrez F.

Medicine (Baltimore). 2016 Mar;95(11):e3108. doi: 10.1097/MD.0000000000003108.

30.

Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy.

Estrada V, Monge S, Gómez-Garre MD, Sobrino P, Masiá M, Berenguer J, Portilla J, Viladés C, Martínez E, Blanco JR; CoRIS and the HIV Biobank integrated in the Spanish AIDS Research Network.

HIV Med. 2016 Oct;17(9):653-61. doi: 10.1111/hiv.12368. Epub 2016 Mar 3.

31.

Withdrawing inactive NRTIs in HIV-1 subjects with suppressed viraemia: a randomized trial.

Llibre JM, Alvarez H, Antela A, Toro J, Payeras A, Pérez-Elías MJ, Imaz A, Masià M, Pérez-Alvarez N, Burgos J, Clotet B; Members of the Nuke-Out Study.

J Antimicrob Chemother. 2016 May;71(5):1346-51. doi: 10.1093/jac/dkv461. Epub 2016 Jan 23.

PMID:
26803719
32.

Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences.

Santos JR, Blanco JL, Masiá M, Gutiérrez F, Pérez-Elías MJ, Iribarren JA, Force L, Antela A, Knobel H, Salavert M, López Bernaldo De Quirós JC, Pino M, Paredes R, Clotet B; Integrase Resistance Study Group in Spain (INI-VAIN Study Group); Integrase Resistance Study Group in Spain INI-VAIN Study Group.

J Antimicrob Chemother. 2015 Nov;70(11):3087-95. doi: 10.1093/jac/dkv205. Epub 2015 Jul 30.

PMID:
26490727
33.

Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors.

Geskus RB, González C, Torres M, Del Romero J, Viciana P, Masiá M, Blanco JR, Iribarren M, De Sanjosé S, Hernández-Novoa B, Ortiz M, Del Amo J; CoRIS-HPV Study Group.

AIDS. 2016 Jan 2;30(1):37-44. doi: 10.1097/QAD.0000000000000874.

34.

Genetic and Pathological Follow-Up Study of Goats Experimentally and Naturally Exposed to a Sheep Scrapie Isolate.

Maestrale C, Cancedda MG, Pintus D, Masia M, Nonno R, Ru G, Carta A, Demontis F, Santucciu C, Ligios C.

J Virol. 2015 Oct;89(19):10044-52. doi: 10.1128/JVI.01262-15. Epub 2015 Jul 22.

35.

The interplay between dynamic heterogeneities and structure of bulk liquid water: A molecular dynamics simulation study.

Demontis P, Gulín-González J, Masia M, Sant M, Suffritti GB.

J Chem Phys. 2015 Jun 28;142(24):244507. doi: 10.1063/1.4922930.

PMID:
26133441
36.

[Deaths due to non-AIDS diseases among HIV infected patients: A 14-year study (1998-2011)].

López C, Masiá M, Padilla S, Aquilino A, Bas C, Gutiérrez F.

Enferm Infecc Microbiol Clin. 2016 Apr;34(4):222-7. doi: 10.1016/j.eimc.2015.04.010. Epub 2015 Jun 18. Spanish.

PMID:
26093959
37.

Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes.

Llibre JM, Rivero A, Rojas JF, Garcia Del Toro M, Herrero C, Arroyo D, Pineda JA, Pasquau J, Masiá M, Crespo M, Blanco JR, Moreno S.

Antiviral Res. 2015 Aug;120:79-84. doi: 10.1016/j.antiviral.2015.05.001. Epub 2015 May 12.

PMID:
25977241
38.

Cardiovascular risk factors and lifetime risk estimation in HIV-infected patients under antiretroviral treatment in Spain.

Estrada V, Bernardino JI, Masiá M, Iribarren JA, Ortega A, Lozano F, Miralles C, Olalla J, Santos J, Elías MJ, Domingo P, Cruz AF.

HIV Clin Trials. 2015 Mar-Apr;16(2):57-65. doi: 10.1179/1528433614Z.0000000008. Epub 2015 Jan 22.

PMID:
25874992
39.

Genetic and pathological characteristics of Cryptococcus gattii and Cryptococcus neoformans var. neoformans from meningoencephalitis in autochthonous goats and mouflons, Sardinia, Italy.

Maestrale C, Masia M, Pintus D, Lollai S, Kozel TR, Gates-Hollingsworth MA, Cancedda MG, Cabras P, Pirino S, D'Ascenzo V, Ligios C.

Vet Microbiol. 2015 Jun 12;177(3-4):409-13. doi: 10.1016/j.vetmic.2015.03.008. Epub 2015 Mar 17.

PMID:
25840469
40.

[Teaching infectious diseases in the Medical Degree within the European higher education area].

Gutiérrez F, Masiá M.

Enferm Infecc Microbiol Clin. 2016 Jun-Jul;34(6):372-83. doi: 10.1016/j.eimc.2015.01.016. Epub 2015 Mar 5. Spanish.

PMID:
25746206
41.

[Vitamin D deficiency: one more piece of the puzzle of cardiovascular risk in human immunodeficiency virus-infected patients?].

Masiá M, Gutiérrez F.

Med Clin (Barc). 2015 Feb 2;144(3):118-20. doi: 10.1016/j.medcli.2014.09.009. Epub 2014 Dec 9. Spanish. No abstract available.

PMID:
25500352
42.

First human systemic infection caused by Spiroplasma.

Aquilino A, Masiá M, López P, Galiana AJ, Tovar J, Andrés M, Gutiérrez F.

J Clin Microbiol. 2015 Feb;53(2):719-21. doi: 10.1128/JCM.02841-14. Epub 2014 Nov 26.

43.

Anal tuberculosis complicating anti-TNFα therapy.

Luquín N, Masiá M, Noguera R, Gutiérrez F.

BMJ Case Rep. 2014 Nov 24;2014. pii: bcr2014206976. doi: 10.1136/bcr-2014-206976.

44.

Telaprevir or boceprevir in HIV/HCV-1 co-infected patients in a real-life setting. Interim analysis (24 weeks). COINFECOVA-SEICV study.

Minguez C, Ortega E, Flores J, Carmena J, Masiá M, Montero M, Reus S, Tornero C, Galindo MJ, Garcia-Deltoro M, Amador C, Cuadrado JM, Usó J, López-Aldeguer J.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19634. doi: 10.7448/IAS.17.4.19634. eCollection 2014.

45.

Molecular epizootiology and diagnosis of porcine babesiosis in Sardinia, Italy.

Zobba R, Nuvoli AM, Sotgiu F, Lecis R, Spezzigu A, Dore GM, Masia MA, Cacciotto C, Parpaglia ML, Dessì D, Pittau M, Alberti A.

Vector Borne Zoonotic Dis. 2014 Oct;14(10):716-23. doi: 10.1089/vbz.2014.1648.

PMID:
25325315
46.

Hydrogen Bonding and Related Properties in Liquid Water: A Car-Parrinello Molecular Dynamics Simulation Study.

Guardia E, Skarmoutsos I, Masia M.

J Phys Chem B. 2015 Jul 23;119(29):8926-38. doi: 10.1021/jp507196q. Epub 2014 Oct 31.

PMID:
25313871
47.

Physical exercise and health.

Cordero A, Masiá MD, Galve E.

Rev Esp Cardiol (Engl Ed). 2014 Sep;67(9):748-53. doi: 10.1016/j.rec.2014.04.005. Epub 2014 Jul 4.

PMID:
25172071
48.

Coinfection with human herpesvirus 8 is associated with persistent inflammation and immune activation in virologically suppressed HIV-infected patients.

Masiá M, Robledano C, Ortiz de la Tabla V, Antequera P, Lumbreras B, Hernández I, Gutiérrez F.

PLoS One. 2014 Aug 18;9(8):e105442. doi: 10.1371/journal.pone.0105442. eCollection 2014.

49.

Long-term effects of an intensive intervention in HIV-infected patients with moderate-high atherosclerotic cardiovascular risk.

Masiá M, Bernal E, Robledano C, Padilla S, López N, Martínez E, Gutiérrez F.

J Antimicrob Chemother. 2014 Nov;69(11):3051-6. doi: 10.1093/jac/dku269. Epub 2014 Jul 18.

PMID:
25038306
50.

Prognostic value of the INTERHEART-cholesterol risk score in patients hospitalized for chest pain.

Cordero A, López-Palop R, Carrillo P, Miralles B, Masiá MD, Bertomeu-Martínez V.

Rev Esp Cardiol (Engl Ed). 2014 Jul;67(7):578-80. doi: 10.1016/j.rec.2014.02.011. Epub 2014 May 29. No abstract available.

PMID:
24952402

Supplemental Content

Support Center